Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 612

1.
2.
3.

Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.

Thøgersen AM, Söderberg S, Jansson JH, Dahlén G, Boman K, Nilsson TK, Lindahl B, Weinehall L, Stenlund H, Lundberg V, Johnson O, Ahrén B, Hallmans G.

Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):33-40.

PMID:
15167204
[PubMed - indexed for MEDLINE]
4.

Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.

Mannucci PM, Bernardinelli L, Foco L, Galli M, Ribichini F, Tubaro M, Peyvandi F.

J Thromb Haemost. 2005 Feb;3(2):280-6.

PMID:
15670033
[PubMed - indexed for MEDLINE]
5.

Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB.

Stroke. 1996 Jun;27(6):1066-71.

PMID:
8650716
[PubMed - indexed for MEDLINE]
Free Article
6.

Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.

Thøgersen AM, Nilsson TK, Weinehall L, Boman K, Eliasson M, Hallmans G, Jansson JH.

Blood Coagul Fibrinolysis. 2009 Jul;20(5):340-6. doi: 10.1097/MBC.0b013e32832a5fd1.

PMID:
19357504
[PubMed - indexed for MEDLINE]
7.

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.

Metabolism. 1997 Nov;46(11):1287-93.

PMID:
9361687
[PubMed - indexed for MEDLINE]
8.

Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.

Segarra A, Chacón P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolomé J, Camps J, Moliner E, Pelegrí A, Marco F, Olmos A, Piera L.

J Am Soc Nephrol. 2001 Jun;12(6):1255-63.

PMID:
11373350
[PubMed - indexed for MEDLINE]
Free Article
10.

The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.

Nordenhem A, Leander K, Hallqvist J, de Faire U, Sten-Linder M, Wiman B.

Thromb Res. 2005;116(3):223-32. Epub 2005 Jan 16.

PMID:
15935831
[PubMed - indexed for MEDLINE]
11.

Leptin is associated with increased risk of myocardial infarction.

Söderberg S, Ahrén B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T.

J Intern Med. 1999 Oct;246(4):409-18.

PMID:
10583712
[PubMed - indexed for MEDLINE]
12.

The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase.

Nilsson JB, Boman K, Jansson JH, Nilsson T, Näslund U.

J Thromb Thrombolysis. 2008 Dec;26(3):188-95. Epub 2007 Aug 25.

PMID:
17721741
[PubMed - indexed for MEDLINE]
13.

Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program.

Janszky I, Hallqvist J, Tomson T, Ahlbom A, Mukamal KJ, Ahnve S.

Brain. 2009 Oct;132(Pt 10):2798-804. doi: 10.1093/brain/awp216. Epub 2009 Aug 28.

PMID:
19717532
[PubMed - indexed for MEDLINE]
Free Article
14.

Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.

Akanji AO, Abdullah A, Tahzeeb S.

Eur J Clin Invest. 1997 May;27(5):380-6.

PMID:
9179544
[PubMed - indexed for MEDLINE]
15.

Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.

Soeki T, Tamura Y, Fukuda N, Ito S.

Jpn Circ J. 2000 Aug;64(8):547-53.

PMID:
10952148
[PubMed - indexed for MEDLINE]
Free Article
16.

Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH.

Lancet. 1993 May 8;341(8854):1165-8.

PMID:
8098074
[PubMed - indexed for MEDLINE]
17.

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH.

Circulation. 1992 May;85(5):1822-7.

PMID:
1572039
[PubMed - indexed for MEDLINE]
18.

Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology.

Zunker P, Schick A, Padró T, Kienast J, Phillips A, Ringelstein EB.

Neurol Res. 1999 Dec;21(8):727-32.

PMID:
10596380
[PubMed - indexed for MEDLINE]
19.

Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.

Chen HZ, Jia HY, Song HY, Wang JY.

Chin Med J (Engl). 1990 Jul;103(7):541-5.

PMID:
2119970
[PubMed - indexed for MEDLINE]
Free Article
20.

Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.

Hernestål-Boman J, Norberg M, Jansson JH, Eliasson M, Eriksson JW, Lindahl B, Johansson L.

Cardiovasc Diabetol. 2012 Dec 18;11:152. doi: 10.1186/1475-2840-11-152.

PMID:
23249721
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk